goldman sachs has upgraded ge healthcare's stock, citing a stabilizing market in China and increased earnings forecasts. Analyst david roman raised the stock's price target, anticipating growth above previous estimates despite tariff concerns.

goldman sachs is upgrading ge healthcare amid improving market outlook.

ge healthcare's stock is upgraded due to improvements in the Chinese market.

david roman is the analyst who upgraded ge healthcare's stock.

donald trump is mentioned in relation to tariff policies affecting stocks.